Asia Pacific Heparin Market By Type (Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin), By Application (Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications), By Route of Administration (Subcutaneous and Intravenous), By End Use (Outpatient and Inpatient), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

The Asia Pacific Heparin Market would witness market growth of 7.8% CAGR during the forecast period (2021-2027).

Heparin refers to an anticoagulant compound that helps in preventing the formation of blood clots. It is used before surgery as it reduces the risk of blood clots in the arteries, veins, or lungs. Therefore, the demand for heparin has been increased over the past few years owing to the increasing geriatric population who are at greater risk of chronic diseases. There is increasing demand for these surgeries which, in turn, fuel the demand for heparin in the healthcare sector. These factors are likely to boost the growth of the market.

There is the availability of various synthetic and semi-synthetic heparin mimetics that are helpful in treating cancer, preventing blood coagulation during surgeries, and in the treatment of inflammatory diseases. This is the major factor which would offer lucrative opportunities for heparin adoption. Moreover, governments of various countries have undertaken initiatives to support healthcare infrastructure improvements. They are raising funds for comprehensive R&D activities that, in turn, fuel the development of new drugs with enhanced therapeutic potential. These factors are driving the growth of the heparin market during the forecast period. Organizations like the CDC and the National Institutes of Health (NIH) are also providing support for the R&D that will develop novel drugs and they have taken various initiatives programs to increase awareness among people.

The demand for heparin in the treatment of blood-related disorders is high in the Asia pacific. It is attributed to constantly improving healthcare infrastructure in this region. Apart from it, there i are many untapped opportunities and increasing initiatives undertaken by private and public organizations which are also contributing to the rapid growth of the heparin market in this region. Healthcare expenditure has also increased in past few years in developing nations. This is likely to have a tremendous effect on the heparin market in the Asia Pacific. For example, China is planning to improve its public health infrastructure that will boost the treatment capabilities of various diseases according to a plan that was released by the National Development and Reform Commission. The demand for heparin has been increased in China in the past decade. In the next decade, the production and demand for heparin are expected to grow.

The China market dominated the Asia Pacific Intravenous Market by Region 2020, thereby, achieving a market value of $280.2 million by 2027. The Japan market is showcasing a CAGR of 7.8% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 9.1% during (2021 - 2027).

Based on Type, the market is segmented into Low Molecular Weight Heparin, Unfractionated Heparin and Ultra-low Molecular Weight Heparin. Based on Application, the market is segmented into Atrial Fibrillation, Coronary Artery Disease, Venous Thromboembolism, Renal Impairment and Other Applications. Based on Route of Administration, the market is segmented into Subcutaneous and Intravenous. Based on End Use, the market is segmented into Outpatient and Inpatient. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Heparin Market is Projected to reach USD 10 Billion by 2027, at a CAGR of 6.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer, Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, and Viatris, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Low Molecular Weight Heparin
• Unfractionated Heparin
• Ultra-low Molecular Weight Heparin

By Application

• Atrial Fibrillation
• Coronary Artery Disease
• Venous Thromboembolism
• Renal Impairment
• Other Applications

By Route of Administration

• Subcutaneous
• Intravenous

By End Use

• Outpatient
• Inpatient

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Baxter International, Inc.
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Pfizer, Inc.
• Sanofi S.A.
• Teva Pharmaceuticals Industries Ltd.
• Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
• Dr. Reddy’s Laboratories Ltd.
• LEO Pharma A/S
• Viatris, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Heparin Market, by Type
1.4.2 Asia Pacific Heparin Market, by Application
1.4.3 Asia Pacific Heparin Market, by Route of Administration
1.4.4 Asia Pacific Heparin Market, by End Use
1.4.5 Asia Pacific Heparin Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Heparin Market by Type
3.1 Asia Pacific Low Molecular Weight Heparin Market by Country
3.2 Asia Pacific Unfractionated Heparin Market by Country
3.3 Asia Pacific Ultra-low Molecular Weight Heparin Market by Country

Chapter 4. Asia Pacific Heparin Market by Application
4.1 Asia Pacific Atrial Fibrillation Market by Country
4.2 Asia Pacific Coronary Artery Disease Market by Country
4.3 Asia Pacific Venous Thromboembolism Market by Country
4.4 Asia Pacific Renal Impairment Market by Country
4.5 Asia Pacific Other Applications Market by Country

Chapter 5. Asia Pacific Heparin Market by Route of Administration
5.1 Asia Pacific Subcutaneous Market by Region
5.2 Asia Pacific Intravenous Market by Region

Chapter 6. Asia Pacific Heparin Market by End Use
6.1 Asia Pacific Outpatient Market by Country
6.2 Asia Pacific Inpatient Market by Country

Chapter 7. Asia Pacific Heparin Market by Region
7.1 China Heparin Market
7.1.1 China Heparin Market by Type
7.1.2 China Heparin Market by Application
7.1.3 China Heparin Market by Route of Administration
7.1.4 China Heparin Market by End Use
7.2 Japan Heparin Market
7.2.1 Japan Heparin Market by Type
7.2.2 Japan Heparin Market by Application
7.2.3 Japan Heparin Market by Route of Administration
7.2.4 Japan Heparin Market by End Use
7.3 India Heparin Market
7.3.1 India Heparin Market by Type
7.3.2 India Heparin Market by Application
7.3.3 India Heparin Market by Route of Administration
7.3.4 India Heparin Market by End Use
7.4 South Korea Heparin Market
7.4.1 South Korea Heparin Market by Type
7.4.2 South Korea Heparin Market by Application
7.4.3 South Korea Heparin Market by Route of Administration
7.4.4 South Korea Heparin Market by End Use
7.5 Singapore Heparin Market
7.5.1 Singapore Heparin Market by Type
7.5.2 Singapore Heparin Market by Application
7.5.3 Singapore Heparin Market by Route of Administration
7.5.4 Singapore Heparin Market by End Use
7.6 Malaysia Heparin Market
7.6.1 Malaysia Heparin Market by Type
7.6.2 Malaysia Heparin Market by Application
7.6.3 Malaysia Heparin Market by Route of Administration
7.6.4 Malaysia Heparin Market by End Use
7.7 Rest of Asia Pacific Heparin Market
7.7.1 Rest of Asia Pacific Heparin Market by Type
7.7.2 Rest of Asia Pacific Heparin Market by Application
7.7.3 Rest of Asia Pacific Heparin Market by Route of Administration
7.7.4 Rest of Asia Heparin Market by End Use

Chapter 8. Company Profiles
8.1 Baxter International, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Fresenius SE & Co. KGaA
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.1 Recent strategies and developments:
8.3.1.1 Partnerships, Collaborations, and Agreements:
8.3.1.2 Acquisition and Mergers:
8.3.1.3 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Sanofi S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.7 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
8.7.1 Company Overview
8.8 Dr. Reddy’s Laboratories Ltd.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 LEO Pharma A/S
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. Viatris, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense

TABLE 1 Asia Pacific Heparin Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Heparin Market, 2021 - 2027, USD Million
TABLE 3 Asia Pacific Heparin Market by Type, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Heparin Market by Type, 2021 - 2027, USD Million
TABLE 5 Asia Pacific Low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 7 Asia Pacific Unfractionated Heparin Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Unfractionated Heparin Market by Country, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Ultra-low Molecular Weight Heparin Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Ultra-low Molecular Weight Heparin Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Heparin Market by Application, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Heparin Market by Application, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Atrial Fibrillation Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Atrial Fibrillation Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Coronary Artery Disease Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Coronary Artery Disease Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Venous Thromboembolism Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Venous Thromboembolism Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Renal Impairment Market by Country, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Renal Impairment Market by Country, 2021 - 2027, USD Million
TABLE 21 Asia Pacific Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 23 Asia Pacific Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 24 Asia Pacific Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 25 Asia Pacific Subcutaneous Market by Region, 2017 - 2020, USD Million
TABLE 26 Asia Pacific Subcutaneous Market by Region, 2021 - 2027, USD Million
TABLE 27 Asia Pacific Intravenous Market by Region, 2017 - 2020, USD Million
TABLE 28 Asia Pacific Intravenous Market by Region, 2021 - 2027, USD Million
TABLE 29 Asia Pacific Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 30 Asia Pacific Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 31 Asia Pacific Outpatient Market by Country, 2017 - 2020, USD Million
TABLE 32 Asia Pacific Outpatient Market by Country, 2021 - 2027, USD Million
TABLE 33 Asia Pacific Inpatient Market by Country, 2017 - 2020, USD Million
TABLE 34 Asia Pacific Inpatient Market by Country, 2021 - 2027, USD Million
TABLE 35 Asia Pacific Heparin Market by Region, 2017 - 2020, USD Million
TABLE 36 Asia Pacific Heparin Market by Region, 2021 - 2027, USD Million
TABLE 37 China Heparin Market, 2017 - 2020, USD Million
TABLE 38 China Heparin Market, 2021 - 2027, USD Million
TABLE 39 China Heparin Market by Type, 2017 - 2020, USD Million
TABLE 40 China Heparin Market by Type, 2021 - 2027, USD Million
TABLE 41 China Heparin Market by Application, 2017 - 2020, USD Million
TABLE 42 China Heparin Market by Application, 2021 - 2027, USD Million
TABLE 43 China Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 44 China Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 45 China Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 46 China Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 47 Japan Heparin Market, 2017 - 2020, USD Million
TABLE 48 Japan Heparin Market, 2021 - 2027, USD Million
TABLE 49 Japan Heparin Market by Type, 2017 - 2020, USD Million
TABLE 50 Japan Heparin Market by Type, 2021 - 2027, USD Million
TABLE 51 Japan Heparin Market by Application, 2017 - 2020, USD Million
TABLE 52 Japan Heparin Market by Application, 2021 - 2027, USD Million
TABLE 53 Japan Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 54 Japan Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 55 Japan Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 56 Japan Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 57 India Heparin Market, 2017 - 2020, USD Million
TABLE 58 India Heparin Market, 2021 - 2027, USD Million
TABLE 59 India Heparin Market by Type, 2017 - 2020, USD Million
TABLE 60 India Heparin Market by Type, 2021 - 2027, USD Million
TABLE 61 India Heparin Market by Application, 2017 - 2020, USD Million
TABLE 62 India Heparin Market by Application, 2021 - 2027, USD Million
TABLE 63 India Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 64 India Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 65 India Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 66 India Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 67 South Korea Heparin Market, 2017 - 2020, USD Million
TABLE 68 South Korea Heparin Market, 2021 - 2027, USD Million
TABLE 69 South Korea Heparin Market by Type, 2017 - 2020, USD Million
TABLE 70 South Korea Heparin Market by Type, 2021 - 2027, USD Million
TABLE 71 South Korea Heparin Market by Application, 2017 - 2020, USD Million
TABLE 72 South Korea Heparin Market by Application, 2021 - 2027, USD Million
TABLE 73 South Korea Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 74 South Korea Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 75 South Korea Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 76 South Korea Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 77 Singapore Heparin Market, 2017 - 2020, USD Million
TABLE 78 Singapore Heparin Market, 2021 - 2027, USD Million
TABLE 79 Singapore Heparin Market by Type, 2017 - 2020, USD Million
TABLE 80 Singapore Heparin Market by Type, 2021 - 2027, USD Million
TABLE 81 Singapore Heparin Market by Application, 2017 - 2020, USD Million
TABLE 82 Singapore Heparin Market by Application, 2021 - 2027, USD Million
TABLE 83 Singapore Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 84 Singapore Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 85 Singapore Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 86 Singapore Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 87 Malaysia Heparin Market, 2017 - 2020, USD Million
TABLE 88 Malaysia Heparin Market, 2021 - 2027, USD Million
TABLE 89 Malaysia Heparin Market by Type, 2017 - 2020, USD Million
TABLE 90 Malaysia Heparin Market by Type, 2021 - 2027, USD Million
TABLE 91 Malaysia Heparin Market by Application, 2017 - 2020, USD Million
TABLE 92 Malaysia Heparin Market by Application, 2021 - 2027, USD Million
TABLE 93 Malaysia Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 94 Malaysia Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 95 Malaysia Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 96 Malaysia Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 97 Rest of Asia Pacific Heparin Market, 2017 - 2020, USD Million
TABLE 98 Rest of Asia Pacific Heparin Market, 2021 - 2027, USD Million
TABLE 99 Rest of Asia Pacific Heparin Market by Type, 2017 - 2020, USD Million
TABLE 100 Rest of Asia Pacific Heparin Market by Type, 2021 - 2027, USD Million
TABLE 101 Rest of Asia Pacific Heparin Market by Application, 2017 - 2020, USD Million
TABLE 102 Rest of Asia Pacific Heparin Market by Application, 2021 - 2027, USD Million
TABLE 103 Rest of Asia Pacific Heparin Market by Route of Administration, 2017 - 2020, USD Million
TABLE 104 Rest of Asia Pacific Heparin Market by Route of Administration, 2021 - 2027, USD Million
TABLE 105 Rest of Asia Pacific Heparin Market by End Use, 2017 - 2020, USD Million
TABLE 106 Rest of Asia Pacific Heparin Market by End Use, 2021 - 2027, USD Million
TABLE 107 Key Information – Baxter International, Inc.
TABLE 108 key Information – B. Braun Melsungen AG
TABLE 109 key information – Fresenius SE & Co. KGaA
TABLE 110 Key Information – Pfizer, Inc.
TABLE 111 Key Information – Sanofi S.A.
TABLE 112 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 113 key information – Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
TABLE 114 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 115 key information – LEO Pharma A/S
TABLE 116 key information – Viatris, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Fresenius SE & Co. KGaA